These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27329843)

  • 41. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
    Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
    Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK/FOXO1 signaling pathway.
    Zeng CX; Fu SB; Feng WS; Zhao JY; Li FX; Gao P
    Neoplasma; 2019 Jan; 66(1):46-53. PubMed ID: 30509085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
    Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FOXR2 contributes to cell proliferation and malignancy in human hepatocellular carcinoma.
    Wang X; He B; Gao Y; Li Y
    Tumour Biol; 2016 Aug; 37(8):10459-67. PubMed ID: 26846213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of EPS8L3 promotes cell proliferation by inhibiting the transactivity of FOXO1 in HCC.
    Zeng CX; Tang LY; Xie CY; Li FX; Zhao JY; Jiang N; Tong Z; Fu SB; Wen FJ; Feng WS
    Neoplasma; 2018 Sep; 65(5):701-707. PubMed ID: 29940761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway.
    Liu H; Xu J; Zhou L; Yun X; Chen L; Wang S; Sun L; Wen Y; Gu J
    Cancer Res; 2011 Dec; 71(24):7547-57. PubMed ID: 21994334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9.
    Kuriyama H; Shimomura I; Kishida K; Kondo H; Furuyama N; Nishizawa H; Maeda N; Matsuda M; Nagaretani H; Kihara S; Nakamura T; Tochino Y; Funahashi T; Matsuzawa Y
    Diabetes; 2002 Oct; 51(10):2915-21. PubMed ID: 12351427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Systematic Characterization of Aquaporin-9 Expression in Human Normal and Pathological Tissues.
    Lindskog C; Asplund A; Catrina A; Nielsen S; Rützler M
    J Histochem Cytochem; 2016 May; 64(5):287-300. PubMed ID: 27026296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Annexin A11 knockdown inhibits in vitro proliferation and enhances survival of Hca-F cell via Akt2/FoxO1 pathway and MMP-9 expression.
    Liu S; Wang J; Guo C; Qi H; Sun MZ
    Biomed Pharmacother; 2015 Mar; 70():58-63. PubMed ID: 25776480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
    Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
    Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
    Tu W; Luo M; Wang Z; Yan W; Xia Y; Deng H; He J; Han P; Tian D
    Liver Int; 2012 Aug; 32(7):1064-78. PubMed ID: 22583549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
    Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.